Our Work

Despite clear evidence that hormonal fluctuations during menstruation impact blood glucose, these effects are often overlooked in diabetes care.

dQ&A presented three research abstracts at the 85th Scientific Sessions of the American Diabetes Association (ADA), the world’s largest diabetes conference.

dQ&A is announcing the availability of new data collected this quarter from ten thousand people with diabetes in the USA, Canada and seven EU countries.

Drivers Analysis is a sophisticated statistical technique that delivers penetrating, next-level insights by disentangling the underlying causes of specific outcomes – so you learn not only ’what’ but ‘why’.

Results from dQ&A Patient Voice Q1 2025 Update

Given that T1D patients share many of the same comorbidities as T2D patients, doctors have been prescribing them to T1D patients ‘off label’.

This study examines how patient trust in AID systems correlates with the perceived effectiveness of the system and how they alleviate diabetes management burdens.

This study assesses how third-party digital health apps (those not specifically tied to a diabetes device) impact glycemic control, mental well-being, and BMI. ‍